The former UFC middleweight champion has been removed from UFC Shanghai…
Anderson Silva was scheduled to face Kelvin Gastelum on November 25th, 2017. He has now been removed from the bout which was to emanate from Shanghai, China. For the second time in his career, Anderson Silva has been flagged by USADA for a potential doping violation.
Silva’s first such violation came following his victory over Nick Diaz at UFC 183. His win would eventually be ruled a no-contest after Silva tested positive for two anabolic steroids, Drostanolone and Androstane. Diaz also failed a post-fight drug test but for increased levels of marijuana metabolites.
Silva would ultimately claim his failed drug test was as a result of a sketchy sexual performance-enhancing substance he took. His teammate is believed to have acquired the substance for him in Thailand. Silva would ultimately receive a 1-year suspension for the offense.
Following his suspension, Silva fought 3x and was not flagged by USADA again until now.
Anderson Silva’s Sketchy Blue Sexual Enhancement Substance
Regarding Silva’s previous failed drug test, he had the following response when asked if he thought taking such a substance was a good decision:
“No, that didn’t go through my thought process,” Silva responded through his manager and translator, Ed Soares. “I’m human and I make mistakes, and this definitely was a mistake. If I would have known that this supplement that I was taking for something else would’ve had this sort of a problem, I would’ve never taken it in the beginning.”
What Has Silva Failed For This Time?
Technically, the substance which Silva failed for should not be made available until he has his hearing. Historically, however, such information usually comes out before this. Smart money says Chael Sonnen has this information some time tomorrow.
It is difficult to say how this failed drug test relates to his previous one as we do not yet know the substances he tested positive for. NAC chairman, Anthony Marnell, had this to say at Silva’s previous hearing regarding Silva’s possibly having used PEDs throughout his career:
“I’m not taking anything away from Mr. Silva’s career. I think he’s done excellent things. He’s by far one of the top fighters in the world. But this is the first time he’s really been subject to enhanced testing, so it’s hard to put a lot of credibility into his prior test results — not his career, but his prior test results.”
UFC Issues Statement on Anderson Silva
The UFC issued their standard statement in response to a fighter’s failed drug test.
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Anderson Silva of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on October 26, 2017. As a result, Silva has been provisionally suspended by USADA. Due to the proximity of Silva’s upcoming scheduled bout at UFC Fight Night, Shanghai, China on November 25, 2017, against Kelvin Gastelum, Silva has been removed from the card and UFC is currently seeking a replacement.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Silva. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. Additional information will be provided at the appropriate time as the process moves forward.